Physician profile
Patrick D Griffith
NPI 1366524076
$3,238.90
in general payments reported to CMS, 2019-2025
9 companies · $22.60 in 2025
The $22.60 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $336 · 2021: $462 · 2022: $486 · 2023: $1,067 · 2024: $738 · 2025: $22.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585 · Travel and Lodging: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.40 |
| Travel and Lodging | $242.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,095.55 | 2021-2024 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Boston Scientific Corporation | $570.68 | 2024-2025 | Intracept |
| Nevro Corp. | $540.30 | 2019-2023 | Senza |
| Medtronic USA, INC. | $336.08 | 2020 | |
| Relievant Medsystems, INC. | $292.81 | 2022-2023 | Intracept |
| Spr Therapeutics, INC | $211.56 | 2021-2023 | Sprint Pns System |
| Abiomed | $167.76 | 2023 | Impella |
| Vertos Medical, INC. | $14.35 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $9.81 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.